Dyslipidemia therapy update: the importance of full lipid profile assessment.

Hdl Handle:
http://hdl.handle.net/10147/253498
Title:
Dyslipidemia therapy update: the importance of full lipid profile assessment.
Authors:
Menown, I B A; Murtagh, G; Maher, V; Cooney, M T; Graham, I M; Tomkin, G
Affiliation:
Craigavon Cardiac Centre, Craigavon BT63 5QQ, Northern Ireland, UK. ian.menown@southerntrust.hscni.net
Citation:
Dyslipidemia therapy update: the importance of full lipid profile assessment. 2009, 26 (7):711-8 Adv Ther
Publisher:
Advances in therapy
Journal:
Advances in therapy
Issue Date:
Jul-2009
URI:
http://hdl.handle.net/10147/253498
DOI:
10.1007/s12325-009-0052-3
PubMed ID:
19649582
Abstract:
Lipid guidelines typically focus on total cholesterol +/- low-density lipoprotein cholesterol levels with less emphasis on high-density lipoprotein cholesterol (HDL-C) or triglyceride assessment, thus potentially underestimating cardiovascular (CV) risk and the need for lifestyle or treatment optimization. In this article, we highlight how reliance on isolated total cholesterol assessment may miss prognostically relevant lipid abnormalities; we describe from the European Systematic COronary Risk Evaluation (SCORE) data set how incorporation of HDL-C may improve estimation of CV risk; and, finally, we critically evaluate the evidence base surrounding triglycerides and CV risk.
Item Type:
Article
Language:
en
MeSH:
Atherosclerosis; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Humans; Practice Guidelines as Topic; Risk Assessment; Triglycerides
ISSN:
0741-238X

Full metadata record

DC FieldValue Language
dc.contributor.authorMenown, I B Aen_GB
dc.contributor.authorMurtagh, Gen_GB
dc.contributor.authorMaher, Ven_GB
dc.contributor.authorCooney, M Ten_GB
dc.contributor.authorGraham, I Men_GB
dc.contributor.authorTomkin, Gen_GB
dc.date.accessioned2012-11-27T15:37:38Z-
dc.date.available2012-11-27T15:37:38Z-
dc.date.issued2009-07-
dc.identifier.citationDyslipidemia therapy update: the importance of full lipid profile assessment. 2009, 26 (7):711-8 Adv Theren_GB
dc.identifier.issn0741-238X-
dc.identifier.pmid19649582-
dc.identifier.doi10.1007/s12325-009-0052-3-
dc.identifier.urihttp://hdl.handle.net/10147/253498-
dc.description.abstractLipid guidelines typically focus on total cholesterol +/- low-density lipoprotein cholesterol levels with less emphasis on high-density lipoprotein cholesterol (HDL-C) or triglyceride assessment, thus potentially underestimating cardiovascular (CV) risk and the need for lifestyle or treatment optimization. In this article, we highlight how reliance on isolated total cholesterol assessment may miss prognostically relevant lipid abnormalities; we describe from the European Systematic COronary Risk Evaluation (SCORE) data set how incorporation of HDL-C may improve estimation of CV risk; and, finally, we critically evaluate the evidence base surrounding triglycerides and CV risk.en_GB
dc.language.isoenen
dc.publisherAdvances in therapyen_GB
dc.rightsArchived with thanks to Advances in therapyen_GB
dc.subject.meshAtherosclerosis-
dc.subject.meshCardiovascular Diseases-
dc.subject.meshCholesterol-
dc.subject.meshCholesterol, HDL-
dc.subject.meshCholesterol, LDL-
dc.subject.meshDyslipidemias-
dc.subject.meshHumans-
dc.subject.meshPractice Guidelines as Topic-
dc.subject.meshRisk Assessment-
dc.subject.meshTriglycerides-
dc.titleDyslipidemia therapy update: the importance of full lipid profile assessment.en_GB
dc.typeArticleen
dc.contributor.departmentCraigavon Cardiac Centre, Craigavon BT63 5QQ, Northern Ireland, UK. ian.menown@southerntrust.hscni.neten_GB
dc.identifier.journalAdvances in therapyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.